Long-term safety and effectiveness of eculizumab in patients with AQP4+neuromyelitis optica spectrum disorder: 3 years of data from Japanese post-marketing surveillance

被引:0
|
作者
Nakahara, Jin [1 ]
Nakashima, Ichiro [2 ]
Yokote, Hiroaki [3 ]
Manabe, Yasuhiro [4 ]
Okamura, Kazumi [5 ]
Hasegawa, Kou [5 ]
Fujihara, Kazuo [6 ,7 ]
机构
[1] Keio Univ, Dept Neurol, Sch Med, Tokyo, Japan
[2] Tohoku Med & Pharmaceut Univ, Div Neurol, Sendai, Japan
[3] Tokyo Metropolitan Komagome Hosp, Dept Neurol, Tokyo, Japan
[4] Natl Hosp Org Okayama Med Ctr, Dept Neurol, Okayama, Japan
[5] Alexion Pharma GK, Tokyo, Japan
[6] Fukushima Med Univ, Fukushima, Japan
[7] Southern TOHOKU Res Inst Neurosci STRINS, Koriyama, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P010/1870
引用
收藏
页码:144 / 144
页数:1
相关论文
共 50 条
  • [31] Long-term Safety and Efficacy of Eculizumab in Asian Patients With Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
    Fujihara, K.
    Berthele, A.
    Kim, H. J.
    Levy, M.
    Palace, J.
    Nakashima, I.
    Totolyan, N.
    Viswanathan, S.
    Wang, K-C.
    Pace, A.
    Armstrong, R.
    Carrillo-Infante, C.
    Miller, L.
    Wingerchuk, D. M.
    Pittock, S. J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP84 - NP85
  • [32] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
    Yamamoto, Fumiko
    Ikeda, Rie
    Ochiai, Kaori
    Hirase, Tetsuaki
    Hayashi, Naoyuki
    Okamura, Tomoo
    DIABETES THERAPY, 2020, 11 (02) : 523 - 533
  • [33] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
    Fumiko Yamamoto
    Rie Ikeda
    Kaori Ochiai
    Tetsuaki Hirase
    Naoyuki Hayashi
    Tomoo Okamura
    Diabetes Therapy, 2020, 11 : 523 - 533
  • [34] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study
    Yamamoto, Fumiko
    Unno, Yuriko
    Okamura, Tomoo
    Ikeda, Rie
    Ochiai, Kaori
    Hayashi, Naoyuki
    DIABETES THERAPY, 2020, 11 (01) : 107 - 117
  • [35] Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study
    Fumiko Yamamoto
    Yuriko Unno
    Tomoo Okamura
    Rie Ikeda
    Kaori Ochiai
    Naoyuki Hayashi
    Diabetes Therapy, 2020, 11 : 107 - 117
  • [36] Safety and effectiveness of tadalafil in patients with pulmonary arterial hypertension: Japanese post-marketing surveillance data
    Yamazaki, Hiroyoshi
    Kobayashi, Noriko
    Taketsuna, Masanori
    Tajima, Koyuki
    Murakami, Masahiro
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (05) : 963 - 971
  • [37] Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance
    Nakamura, Noriko
    Kashitani, Yuka
    Yoshisue, Hajime
    Nagasaki, Makoto
    Sasajima, Takayoshi
    ALLERGOLOGY INTERNATIONAL, 2021, 70 (03) : 319 - 326
  • [38] Long-term Efficacy of Satralizumab in AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar
    Kleiter, Ingo
    Traboulsee, Anthony
    Palace, Jacqueline
    Yamamura, Takashi
    Fujihara, Kazuo
    Saiz, Albert
    Javed, Adil
    Mayes, David
    von Buedingen, H-Christian
    Klingelschmitt, Gaelle
    Stokmaier, Daniela
    Bennett, Jeffrey L.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (01):
  • [39] Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia
    Drulovic, Jelena
    Martinovic, Vanja
    Basuroski, Irena Dujmovic
    Mesaros, Sarlota
    Mader, Simone
    Weinshenker, Brian
    Pekmezovic, Tatjana
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 36
  • [40] Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar
    Yamamura, Takashi
    Weinshenker, Brian
    Yeaman, Michael R.
    De Seze, Jerome
    Patti, Francesco
    Lobo, Patricia
    Von Buedingen, H-Christian
    Kou, Xiujing
    Weber, Kristina
    Greenberg, Benjamin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 66